PALISADE BIO, INC. — Director's Dealing 2023

Sep 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-09-27

Reporting Person: Finley John David (Director, CEO, CFO, Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-27	Common Stock, par value $0.01	P	15000	$0.5392	Acquired	43394	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	777	Indirect

Footnotes

F1: Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023.

F2: Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.